The Times Australia
The Times World News

.

Cannabis for therapeutic use is still out of reach for many sick New Zealanders, despite changes in the law

  • Written by Fiona Hutton, Associate Professor in Criminology, Te Herenga Waka — Victoria University of Wellington
Cannabis for therapeutic use is still out of reach for many sick New Zealanders, despite changes in the law

Access to cannabis-based products for medical reasons is technically legal in New Zealand. But changes to the legislation in 2020 have failed to make this potentially life altering option a reality for many.

Researchers from the University of Otago and Victoria University are exploring the therapeutic use of cannabis in New Zealand through interviews with people who use it to alleviate pain and the symptoms of debilitating illnesses.

Listening to stories of painful, highly complex medical conditions, and the efforts people have made to control their pain with various opioid-based drugs that left them feeling like zombies, has been hard.

But hearing how using cannabis products changed people’s lives and meant they could cut down or, in some cases, completely stop the use of pain killers and other drugs with crippling side effects, has been very positive.

Often these stories involved the work of so-called “green fairies” who focus on producing quality health products and have caring relationships with their patients – but who grow the cannabis illegally.

The role of ‘green fairies’

Some green fairies also have a great deal of knowledge about the potency of their products, what different varieties of cannabis can be used for, and how to prepare and use cannabis products for various conditions.

Read more: Cannabis education should aim to normalize — not prevent — safe and legal use[1]

Those patients who have taken part in the research project so far have talked about cannabis products as a “miracle” and a “life saver” – literally, as some were so overwhelmed by living a life with chronic pain that they sought to end it.

Parents whose children suffered from difficult and sometimes debilitating medical conditions said using cannabis products eased suffering and enabled their children to live “normal” lives.

Self medication of CBD oil using an eye dropper
Cannabis-based products can technically be prescribed by doctors but new research shows most people still access items from illegal sources. David Trood/Getty Images[2]

Miracles at the margins

Yet all these stories – these “miracles” – exist on the margins, as cannabis products are often unattainable[3] outside of the underground illicit market.

Green fairies provide access for patients under constant threat of prosecution[4] themselves.

Ironically, many of those who now sit outside the legal system advocated for the Medicinal Cannabis Bill[5] in 2018. Their success meant the introduction of legislation aimed at large, for-profit corporations with the resources to make products following strict guidelines and complex regulations, but which excludes smaller producers.

Read more: The numbers suggest the campaign for cannabis reform in NZ will outlive the generations that voted against it[6]

Cannabis was first made available in New Zealand for therapeutic purposes in 2010[7], albeit under strict guidelines.

It was not until 2017 that cannabidiol (CBD) products containing non-psychoactive cannabis compounds were able to be prescribed more widely by general practitioners (GPs) without the approval of either the minister or the Ministry of Health.

It took a further three years for products containing tetrahydrocannabinol (THC), the psychoactive cannabis compounds, to be prescribed by GPs without the approval of the government.

For people living with painful, chronic conditions, this was a long time to wait.

Available and accessible? Not quite

The Misuse of Drugs (Medicinal Cannabis) Amendment Act of 2018 and the 2020 Medicinal Cannabis Scheme (MCS), should mean medicinal cannabis products are available and accessible.

Sadly, this is not the case for a large number of people.

Problems include the cost of prescribed cannabis products and the reluctance of GPs to prescribe them, alongside the complex regulatory and compliance scheme accompanying the new law.

Only a small number of products have been approved under the 2020 scheme, mainly due to stringent standards and licence requirements that exclude small producers and growers.

Read more: If reducing harm to society is the goal, a cost-benefit analysis shows cannabis prohibition has failed[8]

Although the cost has reduced in the past few years, the price of products – around $200 per month regardless of whether they are CBD or THC based – is still too high for those on limited incomes.

Research conducted in 2019 found fewer than 5% of respondents got their cannabis products via a GP, with most still accessing cannabis via the underground market[9] or being gifted it by family or friends.

Only 1.56% of interview respondents involved in the current research project access cannabis products through their GP, with several citing cost as a barrier.

GPs are reluctant to prescribe cannabis[10] as an alternative to conventional medications given the lack of clinical studies into its efficacy – despite studies showing[11] the majority of those who used some type of cannabis product therapeutically did so to ease chronic pain.

Bag of cannabis sitting next to a bottle of yellow pills.
Campaigners would like cannabis products to be more accessible. Cappi Thompson/Getty Images[12]

A less complicated approach

The issues involved in developing a more affordable and accessible scheme to enable therapeutic use of cannabis in New Zealand are complex, fraught with seemingly insurmountable barriers, as well as bound by bureaucracy. However, cannabis-based products could be made available without the need for a GP’s prescriptions.

Some therapeutic cannabis products could also be reclassified as natural health products, allowing them to be purchased over the counter as has happened in the United States and Europe.

This approach could bring relief to thousands and give legitimacy to patients, growers and producers seeking to alleviate pain and suffering.

This would also allow[13] clear labelling about dosage, CBD/THC content and warnings about incompatibility with other medications.

Patients would be able to access affordable products more easily and the need for GPs to prescribe products they may not be comfortable with is removed.

Recent legalisation on drug checking[14] also means cannabis products could be tested to ensure some level of product safety.

Such alternative pathways urgently need to be developed, alongside clinical trials.

In the meantime, the bureaucratic processes around what is and isn’t acceptable under complex and onerous regulation grind slowly on, and those with severe and debilitating conditions risk criminalisation or financial hardship to use products that ease their suffering.

References

  1. ^ Cannabis education should aim to normalize — not prevent — safe and legal use (theconversation.com)
  2. ^ David Trood/Getty Images (www.gettyimages.com.au)
  3. ^ often unattainable (www.nzherald.co.nz)
  4. ^ prosecution (www.nzherald.co.nz)
  5. ^ Medicinal Cannabis Bill (www.legislation.govt.nz)
  6. ^ The numbers suggest the campaign for cannabis reform in NZ will outlive the generations that voted against it (theconversation.com)
  7. ^ therapeutic purposes in 2010 (bpac.org.nz)
  8. ^ If reducing harm to society is the goal, a cost-benefit analysis shows cannabis prohibition has failed (theconversation.com)
  9. ^ underground market (pubmed.ncbi.nlm.nih.gov)
  10. ^ reluctant to prescribe cannabis (www.stuff.co.nz)
  11. ^ studies showing (pubmed.ncbi.nlm.nih.gov)
  12. ^ Cappi Thompson/Getty Images (www.gettyimages.com.au)
  13. ^ would also allow (theconversation.com)
  14. ^ drug checking (www.stuff.co.nz)

Read more https://theconversation.com/cannabis-for-therapeutic-use-is-still-out-of-reach-for-many-sick-new-zealanders-despite-changes-in-the-law-184235

Times Magazine

Headless CMS in Digital Twins and 3D Product Experiences

Image by freepik As the metaverse becomes more advanced and accessible, it's clear that multiple sectors will use digital twins and 3D product experiences to visualize, connect, and streamline efforts better. A digital twin is a virtual replica of ...

The Decline of Hyper-Casual: How Mid-Core Mobile Games Took Over in 2025

In recent years, the mobile gaming landscape has undergone a significant transformation, with mid-core mobile games emerging as the dominant force in app stores by 2025. This shift is underpinned by changing user habits and evolving monetization tr...

Understanding ITIL 4 and PRINCE2 Project Management Synergy

Key Highlights ITIL 4 focuses on IT service management, emphasising continual improvement and value creation through modern digital transformation approaches. PRINCE2 project management supports systematic planning and execution of projects wit...

What AI Adoption Means for the Future of Workplace Risk Management

Image by freepik As industrial operations become more complex and fast-paced, the risks faced by workers and employers alike continue to grow. Traditional safety models—reliant on manual oversight, reactive investigations, and standardised checklist...

From Beach Bops to Alpine Anthems: Your Sonos Survival Guide for a Long Weekend Escape

Alright, fellow adventurers and relaxation enthusiasts! So, you've packed your bags, charged your devices, and mentally prepared for that glorious King's Birthday long weekend. But hold on, are you really ready? Because a true long weekend warrior kn...

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Times Features

The Role of Your GP in Creating a Chronic Disease Management Plan That Works

Living with a long-term condition, whether that is diabetes, asthma, arthritis or heart disease, means making hundreds of small decisions every day. You plan your diet against m...

Troubleshooting Flickering Lights: A Comprehensive Guide for Homeowners

Image by rawpixel.com on Freepik Effectively addressing flickering lights in your home is more than just a matter of convenience; it's a pivotal aspect of both home safety and en...

My shins hurt after running. Could it be shin splints?

If you’ve started running for the first time, started again after a break, or your workout is more intense, you might have felt it. A dull, nagging ache down your shins after...

Metal Roof Replacement Cost Per Square Metre in 2025: A Comprehensive Guide for Australian Homeowners

In recent years, the trend of installing metal roofs has surged across Australia. With their reputation for being both robust and visually appealing, it's easy to understand thei...

Why You’re Always Adjusting Your Bra — and What to Do Instead

Image by freepik It starts with a gentle tug, then a subtle shift, and before you know it, you're adjusting your bra again — in the middle of work, at dinner, even on the couch. I...

How to Tell If Your Eyes Are Working Harder Than They Should Be

Image by freepik Most of us take our vision for granted—until it starts to let us down. Whether it's squinting at your phone, rubbing your eyes at the end of the day, or feeling ...